VR MED

The first medical device to employ VR technology for a wide range of uses in medicine.

VR MED is the first medical device in the world to employ VR technology for a wide range of uses. It has similar success not only in ophthalmology, but also neurology and rehabilitation. All you need for the transformation is to put in the required software and configure the system.This equipment covers a large part of the clinic’s needs with VR technology.Development of new directions of diagnostics and treatment of patients is conducted.The technology is patented. VRMD tokens will become an internal currency of the platform, allowing users to get software to extend the functionality of the gadget and support new developments on the platform.

Roadmap

1

Start of the development of the VR headset and programming suitable for medical use.

2

Patent granted in Russia. Start of process to receive international patents.

3

Creation of pilot model of equipment and software for screening for early detection of glaucoma and other conditions with peripheral vision defects. Successful experimental outcomes in the Institute of Eye Diseases at the Russia Academy of Sciences.

4

Participation at international presentations in Lisbon and Bahrain. Introduction of the device.

5

Successful approval process for the device and software at the FH Aachen University of Applied Sciences.

6

Development of the Alpha version of the device, with the capability of providing solutions in ophthalmology (measurement of peripheral vision, diagnosis of glaucoma markers).

7

Development of the device final version (technical and usage fine-tuning), construct improvements.

8

Standard ISO 12866-2011. Industrial design development.

9

Certification of software “Perimeter”: Creation of a universal design for diagnosis of a range of visual functions (through early diagnosis of glaucoma and other peripheral vision field defects).

10

Entrance to the world market: Undergo approval process in India and China clinics; obtain international ISO certification.

11

Upload of users’ data to the platform. Distribution of the device in the European Union, Russia and Asia; Launch of decentralized platform; The 100% functional Perimeter becomes the “gold standard” in ophthalmic diagnosis.

12

Widening of device functionality to include usage in neurology and rehabilitation.

Team

Levon Grigoryan

CEO, Co-founder, patent author

linkedin

Alex Sundukov

COO, SAP, HP, PwC, Philips

linkedin

Ilya Panenkov

Lead Medical Business Developer

linkedin

Dmitriy Mikhailov

Investment Director, Co-founder Aktivo, MTS

linkedin

Ina Glueck

International Business Development, Bionesty Ltd., Representative of VR MED in EU, UK

linkedin

Alexey Ermolaev

Medical leader, MD, Co-founder, Author of patents

linkedin

Grigor Grigoryan

CTO, Co-founder, Patent author

linkedin

Aleksandr Zayanchukovskiy

Lead Design Engineer, Model Specialist

linkedin

Denis Ovod

VR developer, Graphics Programmer Red Machine LLC, W.E.L.L., Diamond Scent Ltd, BioLink

linkedin

Andrey Pravdivtsev

Optical Designer, Optical system modeling

linkedin

Anton Shokurov

Lead Engineer, Mathematician, Algorithm Developer

linkedin

Alex Fominyh

Senior engineer

linkedin

Ekaterina Gromyko

Pr & Marketing specialist

linkedin

Ekaterina Medvedeva

Pr & Marketing specialist

linkedin

Kseniia Deina

SMM manager

linkedin

Konstantin Kotlyar

PhD, Professor of biomedical engineering FH Aachen University of Applied Sciences

linkedin

Alexey Antonov

linkedin

Rating

Pre-sale start

11/13/18

d h m s

Schedule

PRE-SALE

from 11/13/18 to 11/13/18

TOKEN SALE

from 06/07/18 to 07/05/18

Details

Platform: Ethereum

Soft Cap: 1,000,000 USD

Hard Cap: 5,000,000 USD

Token Symbol: vrmd

Total Supply of Tokens: 30,000,000,000 VRMD

Tokens Available for Sale: 20,000,000,000 VRMD

KYC: true

Accepts: BTC, ETH, LTC, Fiat

Registered Company: Cyprus